Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

6.03
Delayed Data
As of Jul 15
 +0.42 / +7.49%
Today’s Change
3.22
Today|||52-Week Range
11.34
+64.31%
Year-to-Date
No recent news for Corvus Pharmaceuticals Inc.

Today’s Trading

Previous close5.61
Today’s open5.61
Day’s range5.60 - 6.15
Volume237,766
Average volume (3 months)142,375
Market cap$164.7M
Data as of 4:00pm ET, 07/15/2019

Growth & Valuation

Earnings growth (last year)+37.27%
Earnings growth (this year)+1.61%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.01-0.41%
AXGTAxovant Gene Therapi...-0.02-0.27%
IDYAIdeaya Biosciences I...-0.31-3.60%
CMRXChimerix Inc0.000.00%
Data as of 4:00pm ET, 07/15/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Richard A. Miller
CFO &
Principal Accounting Officer
Leiv Lea
Corporate headquarters
Burlingame, California

Forecasts